IND-Enabling Programs for Cell and Gene Therapies [Event Recap]
On Thursday, October 22nd, PCI Ventures and Covance co-hosted IND-enabling Programs for Gene & Cell Therapies. Over 30 participants joined the webinar which focused on aspects of a gene and cell therapy preclinical program that are central to an IND submission –namely, in vivo pharmacology, toxicology and pharmacokinetics (PK) assessments using the appropriate models & test systems. Guest speakers included Dr. Brian McIntosh and Dr. Jay Herman. Dr.